与自相关的机制用于治疗多发性髓瘤
Gül Kozalak1,2, Ali Koşar1,2,3
1Faculty of Engineering and Natural Science, Sabancı University, Istanbul 34956, Turkey.
Cancer drug resistance (Alhambra, Calif.)
|January 19, 2024
概括
自会影响多发性骨髓瘤 (MM) 的进展和治疗. 本综述探讨了自机制,基因和药物,以确定MM的最佳治疗策略,强调个性化治疗方法.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种恶性B细胞血液癌.
- 目前的MM治疗包括蛋白酶体抑制剂,免疫调节剂和破坏DNA的药物.
- 自,细胞死亡途径,严重影响MM细胞存活率和治疗疗效.
研究的目的:
- 审查和评估与MM细胞相关的自机制.
- 讨论基因,信号通路和涉及自和MM的药物点.
- 评估自调节药物的疗效和MM治疗中的临床试验.
主要方法:
- 在MM中对自机制的文献综述.
- 分析未折叠蛋白质反应 (UPR),骨髓微环境 (BMME),耐药性,缺氧,DNA修复和亡的作用.
- 检查基因功能和与MM的自相关的研究工作.
- 对MM中自调节剂的药物疗效和临床试验数据的评估.
主要成果:
- 自可以促进MM的进展或阻碍治疗,这取决于背景.
- 特定的自机制和相关基因显示了MM治疗干预的潜力.
- 确定了新的药物标和信号通路,以利用自为MM治疗.
- 临床试验证明了某些自调节药物在MM中的疗效.
结论:
- 某些自机制被认为是最适合MM治疗的.
- 3D模型和微流体系统对于发现新型自药物和实现个性化MM治疗至关重要.
- 本综述提供了对自在MM中的作用的全面概述,指导未来的研究和临床应用.
相关概念视频
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527


